인쇄하기
취소

Inist to jointly develop oral ‘bazedoxifene/cholecalciferol’ combination drug

Published: 2017-09-12 13:47:41
Updated: 2017-09-12 13:47:41

Inist Bio Pharmaceutical(CEO Kook-Hyun Kim) will conduct an open innovation service of its product based on its know-hows as a CMO(contract manufacturing organization).

The company will open a briefing to suggest joint development of a bazedoxifene/cholecalciferol combination drug being developed by the company’s headquarters at 2pm on the 14th of September.

The bazedoxifene substance, an ost...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.